Fundraising Fox

terrestrial

123 employees on LinkedIn · 3 known investors

Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.

Founders & leadership

RS
Rachel ShainCEO

Investors · 3

Competitors · 1

by search overlap

Companies competing with terrestrial for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does terrestrial do?
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.
Who are terrestrial's investors?
terrestrial's investors include RA Capital, The Engine Ventures, Ulu Ventures.